Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

YHC vs ABP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

YHC Wins Head-to-Head Institutional Verdict (2–1 across 6 Pillars · 4–2 Matrix Metrics)

YHC Overall Winner 6-Pillar Tally: YHC 2 – 1 ABP (3 Tie) Matrix Metrics: YHC 4 – 2 ABP

As of Nov 20, 2026, LQR House Inc. (YHC) is the stronger overall head-to-head candidate over Abpro Holdings, Inc (ABP) in the Tradestie Institutional Equity Comparison Engine, winning 4–2 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow). YHC carries a Unified Composite Score of 49.0/100 (HOLD) at $1.59 (N/M Forward P/E, -750.8% operating margin), whereas ABP carries 44.4/100 (HOLD) at $0.52 (N/M Forward P/E, 0.0% operating margin).

  • Technical & Structure Timing Caution: YHC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 42.4); meanwhile ABP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About YHC vs ABP
YHC NASDAQ Head-to-Head Winner
LQR House Inc. Common Stock
Beverages
$1.59
-9.92% 1D
Market Cap $2.3M
TTM Revenue $1.2M
Forward P/E N/M
Beta / 30D Vol -52.25β · 155% Vol
Unified Composite Score
49.0 / 100 HOLD
Tech 40.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.4 · SMA20: $1.98 · SMA50: $1.72
ABP NASDAQ
Abpro Holdings, Inc Common Stock
Biological Products, (No Disgnostic Substances)
$0.52
-34.76% 1D
Market Cap $2.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.33β · 258% Vol
Unified Composite Score
44.4 / 100 HOLD
Tech 40.0 Fund 49.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -36.3%), weak momentum, RSI 22
RSI-14: 22.2 · SMA20: $1.51 · SMA50: $3.29

6-Pillar Scorecard Institutional Category Breakdown (YHC 2 – 1 ABP)

Columns: Metric · YHC · ABP
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale YHC
Revenue Growth (YoY) -2.5% -100.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $1.2M N/A
Market Cap $2.3M $2.2M
3. Profitability & Quality ABP
Gross Margin 7.9% N/A
Operating Margin -750.8% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -7.7% 0.0%
4. Balance Sheet & Cash Flow YHC
Cash Generation (TTM) -$11M EBITDA N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $4.4M Net Cash 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Beverages - Wineries & Distilleries Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: YHC (4) vs ABP (2)
Institutional Metric YHC ABP Criterion Row Edge
Market Capitalization
Scale
$2.3M $2.2M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-2.5% -100.0% Higher Growth YHC
Operating Margin (TTM)
Profitability
-750.8% 0.0% Higher Margin ABP
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-7.7% 0.0% Higher ROE ABP
52-Week Range Position
Momentum
53% ($0–$3) 0% ($1–$32) Stronger Trend YHC
Beta / 30D Volatility
Risk Regime
-52.25β · 155% Vol 2.33β · 258% Vol Lower Realized Risk YHC
Unified Institutional Score
Composite Signal
49.0 / 100 (HOLD) 44.4 / 100 (HOLD) Higher Composite YHC
Trailing 12M Revenue (USD)
Operating Scale
$1.2M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
7.9% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$11M EBITDA ($4.4M Net Cash) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon YHC +74.33 pp
YHC: -9.71% · ABP: -84.04%
3M Horizon YHC +103.78 pp
YHC: +12.27% · ABP: -91.51%
6M Horizon YHC +103.78 pp
YHC: +12.27% · ABP: -91.51%
1Y Horizon YHC +103.78 pp
YHC: +12.27% · ABP: -91.51%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on YHC vs ABP. Trailing 12-month operating profitability (YHC -750.8% vs ABP 0.0%) and valuation multiples (YHC N/M vs ABP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

YHC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.2M
Gross Margin7.9%
Op. Margin-750.8%
ROE / Fwd P/E-7.7% · N/M
ABP ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
YHC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact YHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
YHC Moat Profile Cyclical / Execution-Driven Positioning
Beverages - Wineries & Distilleries Operator
Competes within the Beverages - Wineries & Distilleries value chain with $2.3M market capitalization and -750.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ABP Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $2.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ YHC vs ABP Key Questions & Quantitative Answers

As of Nov 20, 2026, LQR House Inc. (YHC) is the stronger overall head-to-head candidate over Abpro Holdings, Inc (ABP) in the Tradestie Institutional Equity Comparison Engine, winning 4–2 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow). YHC carries a Unified Composite Score of 49.0/100 (HOLD) at $1.59 (N/M Forward P/E, -750.8% operating margin), whereas ABP carries 44.4/100 (HOLD) at $0.52 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: YHC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 42.4); meanwhile ABP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

YHC leads the Growth & Scale pillar: YHC posts -2.5% YoY revenue growth and +0.0% YoY earnings growth on $1.2M TTM revenue (7.9% gross margin, -750.8% operating margin), compared with ABP at -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, YHC generates $1.2M in USD-normalized revenue versus N/A for ABP. In operating R&D and SG&A reinvestment, YHC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABP.

YHC and ABP trade at balanced relative valuation multiples. YHC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin), whereas ABP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against YHC (-7.7% ROE) versus ABP (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, YHC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-52.25β · 155% Vol realized risk). By comparison, ABP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.33β · 258% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.